z-logo
Premium
Ultrafast liquid chromatographic analysis of erdosteine in human plasma based on fluorimetric detection and precolumn derivatization with 4‐bromomethyl‐7‐methoxycoumarin: Application to pharmacokinetic studies
Author(s) -
Onal Cem,
Kepekci Tekkeli Serife Evrim
Publication year - 2020
Publication title -
luminescence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 45
eISSN - 1522-7243
pISSN - 1522-7235
DOI - 10.1002/bio.3780
Subject(s) - derivatization , chromatography , chemistry , pharmacokinetics , human plasma , high performance liquid chromatography , pharmacology , medicine
In this study, a new analytical method for erdosteine (ERD) in plasma based on high‐performance liquid chromatography and a fluorimetric detector, is presented. Precolumn derivatization of ERD with 4‐bromomethyl‐7‐methoxy coumarin (BrMmC) and dibenzo‐18‐crown‐6‐ether as a reaction catalyst led to the production of a fluorescent compound. ERD was monitored by fluorescence with an excitation wavelength λ ext. = 325 nm and emission wavelength λ em. = 390 nm. Optimum reaction conditions were carefully studied and optimized. A chromatographic procedure was performed using a C18 column of 150 × 4.6 mm and 3 μm particle size and a mobile phase consisting of methanol:acetonitrile:water (30:30:40, v /v/v) under a flow rate of 0.5 ml min −1 . A calibration plot was established covering analyte concentration range 0.2–3.0 μg ml −1 ; the detection limit was 0.015 μg ml −1 and quantification limit was 0.05 μg ml −1 . Mean recovery was 87.33% and relative standard deviation was calculated to be less than 4.4%. The developed method was successfully used to determine pharmacokinetic preparations of ERD subsequent to administration of a 900 mg dose capsule to a healthy 40‐year‐old woman volunteer.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here